Form 4 for NEO NEOGENOMICS INC
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001077183-21-000247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-12 | 2021-11-10 | NEO | Daly David | Dir | A - Grant | $0.00 | +1,623 | 1,623 | New | $0 |
| D | 2021-11-12 | 2021-11-10 | NEO | Daly David | Dir | A - Grant | $0.00 | +1,945 | 1,945 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | A | A | 1,623 | $0.00 | 1,623 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-11-10 | A | A | 1,945 | $0.00 | 1,945 | D | $43.39 · 2022-06-02 to 2028-06-02 | 1,945 Common Stock |